Samenvatting
PMLRAR (retinoic acid receptor)α is the hallmark protein of acute promyelocytic leukaemia, a highly malignant subtype of acute myeloid leukaemia that accounts for approximately 10% of all AML cases. Recently, several studies have been set out to obtain a comprehensive genome-wide view of the molecular actions of this chimeric protein. In this review, we highlight the new insights that arose from these studies, in particular focussing on newly identified PML-RARα target genes, its interplay with RXR and deregulation of epigenetic modifications.
| Originele taal-2 | Engels |
|---|---|
| Pagina's (van-tot) | 554-558 |
| Aantal pagina's | 5 |
| Tijdschrift | British journal of cancer |
| Volume | 104 |
| Nummer van het tijdschrift | 4 |
| DOI's | |
| Status | Gepubliceerd - 15 feb. 2011 |
| Extern gepubliceerd | Ja |